| 1-phosphatidylinositol-3-kinase regulator activity |
| phosphatidylinositol 3-kinase complex |
| negative regulation of B cell activation |
| negative regulation of calcium-mediated signaling |
| negative regulation of insulin receptor signaling pathway |
| negative regulation of cellular response to insulin stimulus |
| phosphatidylinositol phosphorylation |
| regulation of phosphatidylinositol 3-kinase activity |
| SH3/SH2 adaptor activity |
| regulation of lipid kinase activity |
| regulation of insulin receptor signaling pathway |
| lipid phosphorylation |
| regulation of cellular response to insulin stimulus |
| regulation of phospholipid metabolic process |
| regulation of calcium-mediated signaling |
| protein N-terminus binding |
| late endosome |
| negative regulation of lymphocyte activation |
| intracellular receptor signaling pathway |
| phosphatidylinositol metabolic process |
| negative regulation of leukocyte activation |
| negative regulation of cell activation |
| lipid modification |
| regulation of B cell activation |
| B cell mediated immunity |
| endosome membrane |
| T cell activation |
| lymphocyte mediated immunity |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| antigen receptor-mediated signaling pathway |
| glycerophospholipid metabolic process |
| phospholipid metabolic process |
| glycerolipid metabolic process |
| lymphocyte activation |
| regulation of lipid metabolic process |
| negative regulation of immune system process |
| immune response-activating cell surface receptor signaling pathway |
| immune response-regulating cell surface receptor signaling pathway |
| negative regulation of intracellular signal transduction |
| regulation of lymphocyte activation |
| immune response-activating signal transduction |
| immune response-regulating signaling pathway |
| regulation of leukocyte activation |
| adaptive immune response |
| activation of immune response |
| regulation of cell activation |
| intracellular membrane-bounded organelle |
| leukocyte mediated immunity |
| negative regulation of transcription by RNA polymerase II |
| positive regulation of immune response |
| regulation of kinase activity |
| organophosphate metabolic process |
| leukocyte activation |
| cellular lipid metabolic process |
| regulation of transferase activity |
| Golgi apparatus |
| cell activation |
| immune effector process |
| regulation of immune response |
| positive regulation of immune system process |
| negative regulation of transcription, DNA-templated |
| lipid metabolic process |
| negative regulation of nucleic acid-templated transcription |
| negative regulation of RNA biosynthetic process |
| negative regulation of signal transduction |
| phosphorylation |
| negative regulation of RNA metabolic process |
| negative regulation of cell communication |
| negative regulation of signaling |
| negative regulation of cellular macromolecule biosynthetic process |
| negative regulation of nucleobase-containing compound metabolic process |
| negative regulation of macromolecule biosynthetic process |
| negative regulation of cellular biosynthetic process |
| negative regulation of biosynthetic process |
| regulation of phosphorylation |
| negative regulation of response to stimulus |
| regulation of immune system process |
| positive regulation of signal transduction |
| negative regulation of gene expression |
| regulation of phosphate metabolic process |
| regulation of phosphorus metabolic process |
| positive regulation of cell communication |
| positive regulation of signaling |
| regulation of intracellular signal transduction |
| immune response |